UBS AM’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
UBS AM's GYRE Position: Q3 2026 in Review
UBS AM reported 7,095 shares of Gyre Therapeutics (GYRE) worth $52K in Q3 2026. The position accounts for ﹤0.01% of the portfolio, ranked #3405.
58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.
- UBS AM held 7,095 shares of Gyre Therapeutics worth $52K as of Q3 2026.
- Gyre Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3405 holding.
- 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.